Skip to content

The role of innate immunity in the pathogenesis of acute respiratory syncytial virus lower respiratory tract infection: Repeated measurements of nasopharyngeal type 1 interferon levels in RSV infections

The role of innate immunity in the pathogenesis of acute respiratory syncytial virus lower respiratory tract infection: Repeated measurements of nasopharyngeal type 1 interferon levels in RSV infections - SNOT'R

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35329
Enrollment
400
Registered
2006-09-18
Start date
2006-10-15
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Innate immune response Viral respiratory tract infection

Interventions

None listed

Sponsors

RSV Research Group van het Wilhelmina Kinderziekenhuis Utrecht, UMCU, onder leiding van Prof. dr. J.L.L. Kimpen, promotor
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Child = under the age of 13 months (exception:

Exclusion criteria

Exclusion criteria: Child = previous airway morbidity or severe co-morbidity (exception: no exclusion criteria for group 3) Adult = None

Design outcomes

Primary

MeasureTime frame
1. Disease severity: Children: Standardised Respiratory Distress Assessment Instrument (RDAI) Score Elderly: Standardised Adult Physiology And Chronic Health (APACHE) Score, Respiratory Parameter 2. Virological analysis (nasopharyngeal material): Quantitative RT-PCR on RSV, hMPV, rhinovirus, adenovirus, PIV 1-4, Flu A en B, en coronavirus 3. Immunological analysis/cytokine concentrations (nasopharyngeal material): Interferon-alfa using commercial ELISA IL-1aβ/a, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12*70, IL-13, IL-15, IL-17, IL-18, IFN-γ and TNF-a using Luminex 4. Immunological analysis (blood): Leucocytes and differentiation Immunophenotyping Toll-like receptor responses

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)